Latest Updates

EBITDA margin reported at 8.3 per cent

Expects to generate a revenue of $5 million within three years of the launch

Helps in reducing health hazards and also increasing safety of consumers

PBT up 52 per cent at Rs 80.49 crores

The consolidated revenue for the quarter ended September 30 was Rs 1197 crore

Amlodipine Besylate tablets is indicated for the treatment of hypertension, to lower blood pressure

EBITDA reported at Rs 362 crores; PAT at Rs 196 crores

Event orgnaised in collaboration with JSS university

University of Salzburg, Sandoz and Thermo Fisher Scientific collaborate to advance protein-based pharmaceutical development

This ranking is the world's largest annual study of workplace excellence and identifies the top-25 best multinationals in terms of…

Dr Vatsal Shah, Global Head, SIRO's Medical writing group to speak on the IT tools and techniques available for improving the…

To provide a combined service for drug development applications in the field of drug targeting and pharmacokinetic improvements

Are prescribed for adjunct treatment of hypercholesterolemia (high blood cholesterol), mixed dyslipidemia and…

The phase III clinical trials for the drug conducted in India successfully demonstrated the efficacy and tolerability of Synriam…

Industrial visit and Scientific Day were the main focus of the week

Indian generics exports growing at 24% per annum

Conference in Mumbai on November 15, 2013 will project thoughts from Indian marketers including some case-studies

Award given in recognition of its outstanding OTF security label specifically developed to protect high security devices and…

First pharmaceutical company globally to adopt ISRS, 8th edition standard

The copmpany had a total of 649 filings for formulations of which 189 have been approved in various regions of the world